Cover Image

Diversity and Dosage Determine the Efficacy of the Probiotic SYN ‐53 in Allergic Rhinoconjunctivitis: A Randomized, Double‐Blind, Placebo‐Controlled Trial

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Karl‐Christian Bergmann, Torsten Zuberbier
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Allergy
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of the Multi‐Strain Probiotic SYN ‐53 in the Management of Allergic Rhinoconjunctivitis
by: Karl‐Christian Bergmann, et al.
Published: (2025)

Efficacy of Using Photobiomodulation Therapy in Allergic Rhinitis: A Placebo‐Controlled Randomized Clinical Trial
by: Patrícia Costa Oliveira, et al.
Published: (2025)

Comparative Efficacy of Intranasal Corticosteroids and Antihistamines in Enhancing Paediatric Quality of Life in Allergic Rhinoconjunctivitis
by: Ellen Tameeris, et al.
Published: (2026)

Letter to the Editor Regarding “Efficacy of Using Photobiomodulation Therapy in Allergic Rhinitis: A Placebo‐Controlled Randomized Clinical Trial”
by: Sanjeev Yadav, et al.
Published: (2025)

Our Response Letter to the Editor Concerning “Efficacy of Using Photobiomodulation Therapy in Allergic Rhinitis: A Placebo‐Controlled Randomized Clinical Trial”
by: Patrícia Costa Oliveira, et al.
Published: (2025)

Modulation of Cellular, Molecular, and Humoral Responses by PQ Grass 27,600 SU for the Treatment of Seasonal Allergic Rhinitis: A Randomised Double Blind Placebo Control Exploratory Field Study
by: Janice A. Layhadi, et al.
Published: (2025)

Acupuncture Combined With Sphenopalatine Ganglion Needling for Allergic Rhinitis: A Randomized Controlled Trial
by: Shanshan Liu, et al.
Published: (2025)

Anxiety, Depression, Schizophrenia, and Bipolar Disorder in Eosinophilic Esophagitis Patients: A Global Federated Cohort Analysis of Bidirectional Risks
by: Hui‐Chin Chang, et al.
Published: (2026)

Codfish Oral Immunotherapy in Children Aged 2–10: Randomized Placebo‐Controlled Study
by: Agnes Sze‐yin Leung, et al.
Published: (2026)

Efficacy of Omalizumab, Dupilumab, and Remibrutinib in Chronic Spontaneous Urticaria: Phase Data and Placebo Response
by: Murat Türk, et al.
Published: (2025)

A Novel Cell Culture System to Improve MRGPRX2 Research in Human Skin Mast Cells
by: Zhuoran Li, et al.
Published: (2025)

CT ‐ P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double‐Blind, Randomized, Active‐Controlled, Phase 3 Study
by: Sarbjit S. Saini, et al.
Published: (2025)

Tetraspanin CD53 Promotes Inflammation but Restrains Mucus Production in a Mouse Model of Allergic Airway Inflammation
by: Amy T. Hsu, et al.
Published: (2024)

Long‐Term Effect of Allergen Immunotherapy in Responder Local Allergic Rhinitis Patients: Symptom Control, and Prevention of Asthma and Allergic Sensitizations
by: Almudena Testera‐Montes, et al.
Published: (2025)

Two‐Year Turning Point With Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Control, Remission, and Tapering Dosage
by: Eugenio De Corso, et al.
Published: (2025)

Impact of Residential Greeness Exposure on the Development of Allergic Diseases and Asthma and on Asthma Control—A Systematic Review for the EAACI Guidelines of Environmental Science for Allergic Diseases and Asthma
by: Ioana Agache, et al.
Published: (2025)

Pollen‐Pharmacotherapy Interaction Impacts Symptom Control in Seasonal Allergic Rhinitis
by: Zengxiao Zhang, et al.
Published: (2026)

Circulating Type 2 Memory B Cell Frequency Is a Biomarker for Allergen Immunotherapy Efficacy in Patients With Allergic Rhinitis
by: Yue Ma, et al.
Published: (2026)

Endoscopic Posterior Nasal Neurectomy Versus Radiofrequency Ablation in Refractory Allergic Rhinitis: A 2‐Year Randomized Controlled Trial of Clinical Outcomes and Immunomodulatory Responses
by: Rui Zheng, et al.
Published: (2026)

Assessment of the Effectiveness of Allergic Rhinitis Medications Using a Target Trial Emulation Approach Based on Mobile Health Data
by: Nuno Lourenço‐Silva, et al.
Published: (2025)

Clinical Benefits of a Randomized Allergy App Intervention in Grass Pollen Sufferers: A Controlled Trial
by: Caroline Holzmann, et al.
Published: (2025)

Maternal Opioid Use and Subsequent Risk of Allergic Diseases in Children: Emulation of Target Trials Using the Korean Nationwide Birth Cohort
by: Hyeon Jin Kim, et al.
Published: (2026)

20 years of the socioeconomic impact of atopic dermatitis and alopecia areata from around the globe
by: Katarina Stevanovic, et al.
Published: (2025)

Availability and Costs of Allergic Rhinitis Treatments Across the World: A Survey of ARIA Experts
by: Maria Clara Urbano, et al.
Published: (2026)

Comparison of Double‐Blind and Open Food Challenges for the Diagnosis of Food Allergy in Childhood: The ALDORADO Study
by: Wouter W. de Weger, et al.
Published: (2024)

Genotype‐Guided Asthma Treatment Reduces Exacerbations in Children: Meta‐Analysis of Two Randomized Control Trials
by: Elise M. A. Slob, et al.
Published: (2024)

Comparison of Allergic Rhinitis Treatments on Utilities and Quality of Life: A MASK ‐air Study
by: Nuno Lourenço‐Silva, et al.
Published: (2026)

A Multicenter, Randomized, Controlled Clinical Trial on the Efficacy and Safety of Eucalyptol, Limonene, and Pinene Enteric Capsules in the Treatment of Chronic Rhinosinusitis With Nasal Polyps Postoperatively
by: Yutong Sima, et al.
Published: (2025)

Protein Glycosylation: An Emerging Regulator of Allergic Diseases
by: Pan Li, et al.
Published: (2025)

Management of Patients With Allergic Diseases in the Era of Biologics
by: Feng Lan, et al.
Published: (2025)

Efficacy and Safety of Subcutaneous vs. Sublingual Immunotherapy in Allergic Rhinitis: A Systematic Review and Meta‐Analysis
by: Shambo Samrat Samajdar, et al.
Published: (2024)

Transcriptomic Profiles of the Nasal Mucosa Following Birch Pollen Provocation Differ Between Birch Pollen‐Allergic and Non‐Allergic Individuals
by: Srinidhi Sudharson, et al.
Published: (2024)

The Causal Relationship Between Serum Metabolites and Allergic Diseases: Mendelian Randomization Analysis
by: Yanli Qiu, et al.
Published: (2024)

Three‐Year Longitudinal Evaluation of Timing Effects on Subcutaneous Immunotherapy Efficacy and Safety in Allergic Rhinitis
by: Hang Li, et al.
Published: (2025)

Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK‐air Study
by: Bernardo Sousa‐Pinto, et al.
Published: (2025)

The Expanding Role of ILC2s in Allergic Airways Disease
by: Jafar Cain, et al.
Published: (2025)

Soybean Oil in Propofol Is Not Able to Induce Allergic Reactions
by: Deniz Eyice Karabacak, et al.
Published: (2024)

Chinese Position Paper on Biologic Therapy for Allergic Rhinitis
by: Yuan Zhang, et al.
Published: (2026)

Cost‐Effectiveness of Allergen Immunotherapy for Allergic Rhinitis: A Systematic Review
by: Joshua Jacob, et al.
Published: (2026)

Efficacy and safety of intranasal medications for allergic rhinitis: Network meta‐analysis
by: Bernardo Sousa‐Pinto, et al.
Published: (2024)